Paper - WANFANG MED ONLINE

You Position: Home > Paper

Acute and chronic liver injury induced by Chinese patent medicine: Causes and precautions

( views:24, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 21

DOI:: 10.11569/wcjd.v26.i21.1273

Key Word:: 中成药;肝毒性;药物性肝损伤;合理用药;Chinese patent medicine;Hepatotoxicity;Drug-induced liver injury;Rational drug usage

Abstract： Chinese patent medicines are popular due to their definite clinical efficacy, reliable quality, and good safety. However, Chinese medicine and its preparations are one of the main causes of drug induced liver damage. The hepatotoxic ingredients of Chinese patent medicines and the irrational application of Chinese patent medicines are the two main reasons for their hepatotoxicity. However, there are no systematic studies on the causes, types, and preventive measures for liver injury caused by Chinese patent medicines. This article aims to briefly review the causes and preventive measures of acute and chronic liver injury caused by Chinese patent medicines.

Reference

[1]夏凯.基于我院近5年临床病案数据库的急性中草药肝损伤流行病学调查及预后随访[D].2016.
[2]吴亚男,罗燕,刘芽青,等.中药引起药物性肝损害原因探析[J].2017,(13).
[3]高学敏,张建军,张德芹,等.中成药质量标准化建设的现状及展望[J].2007,(9).
[4]高廷明,陈学平,罗志刚,等.27例中成药及中药注射液所致急性药物性肝损伤临床分析[J].2017,(16).
[5]袁蒲.87例药物性肝损害用药分析[J].2012,(11).
[6]钟萌.中成药说明书与用药安全相关探讨[J].2011,(12).
[7]李大寿,艾远征,李伟,等.中药致药物性肝损伤81例分析[J].2012,(15).
[8]中华中医药学会肝胆病分会,中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南[J].2016,(5).
[9]王丽霞,李力,谢燕霞,等.含化学药（西药）成分中成药的安全使用[J].2002,(4).
[10]张华,吕彩霞,武鑫,等.药物性肝损伤314例的临床特征风险因素及预后分析[J].2016,(5).
[11]中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].2017,(2).
[12]伍玉南,张冬,张涛,等.基于文献回顾性研究中药药物性肝损伤[J].2017,(1).
[13]李大寿,艾远征.中药致药物性肝损伤的原因与预防措施[J].2011,(28).
[14]侯福平,李野,许晶,等.基于ARMA模型的我国“十二五”时期中成药工业产值预测分析[J].2013,(1).
[15]Tang, Zhi-Shu,Liang, Yan-Ni,Xu, Hong-Bo,etc.The chemistry and pharmacology of Ligularia przewalskii: A review[J].2018,219.
[16]吕爱平,王丽颖.加强中成药合理使用的建议[J].2011,(20).
[17]Ran WangXingshun QiEric M. YoshidaNahum Méndez-SánchezRolf TeschkeMingyu SunXu LiuChunping SuJiao DengHan DengFeifei HouXiaozhong Guo.Ran WangXingshun QiEric M. YoshidaNahum Méndez-SánchezRolf TeschkeMingyu SunXu LiuChunping SuJiao De[J].2018,12(4).
[18]何婷婷,宫嫚,白云峰,等.2种药物性肝损伤诊断指南的应用分析[J].2016,(16).
[19]吴豪,钟荣玲,夏智,等.潜在肝毒性中药的成分研究进展[J].2016,(17).
[20]罗岚,江振洲,张陆勇.雷公藤多苷肝毒性发生机制及减毒相关研究进展[J].2017,(10).
[21]刘睿,李新宇,李亚卓,等.网络毒理学及其在中药毒性成分预测中的应用研究[J].2018,(5).
[22]中华中医药学会肝胆病分会,中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南[J].2016,(6).
[23]Larrey D.Epidemiology and individual susceptibility to adverse drug reactions affecting the liver.[J].2002,22(2).
[24]Teschke,R.,Wolff,A.,Frenzel,C.,etc.Review article: Herbal hepatotoxicity - An update on traditional Chinese medicine preparations[J].2014,40(1).
[25]Longfei, Lin,Hui, Li,Hongmei, Lin,etc.A New Perspective on Liver Injury by Traditional Chinese Herbs Such As Polygonum multiflorum: The Geographical Area of Harvest As an Important Contributory Factor.[J].2017,8(Spec ).
[26]陶明宝,张乐,刘飞,等.含蒽醌类成分中药的安全性研究进展[J].2016,(6).
[27]Miao JW,Wu Q,Liang SX,etc.Evaluation of hepatotoxicity potential of cinnabar-containing An-Gong-Niu-Huang Wan, a patent traditional Chinese medicine.[J].2011,60(2).
[28]Alvin W. T. Ng,Song Ling Poon,Mi Ni Huang,etc.Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia[J].2017,9(412).
[29]孙成春,徐建江.152例药物性肝损伤临床分析[J].2017,(6).
[30]Son, Chang-Gue,Lee, Woo-Jin,Kim, Hae-Won,etc.Systematic review on herb-induced liver injury in Korea[J].2015,84.
[31]Stedman C.Herbal hepatotoxicity.[J].2002,22(2).
[32]杨倩,李晓宇,赵新妹,等.含何首乌的中成药不良反应系统分析[J].2017,(9).
[33]赵凤娥,石振东.中药相关性肝损伤的临床研究进展[J].2017,(30).
[34]Leise,M.D.,Poterucha,J.J.,Talwalkar,J.A..Drug-induced liver injury[J].2014,89(1).
[35]刘莹,仲青香,邱辉辉,等.基于肝毒性的雷公藤中药复方配伍减毒的研究进展[J].2017,(16).
[36]C C, Tsai,C T, Kao,C T, Hsu,etc.Evaluation of four prescriptions of traditional Chinese medicine: syh-mo-yiin, guizhi-fuling-wan, shieh-qing-wan and syh-nih-sann on experimental acute liver damage in rats.[J].1997,55(3).
[37]Peng, Zhang,Yongan, Ye,Xianzhao, Yang,etc.Systematic Review on Chinese Herbal Medicine Induced Liver Injury.[J].2016.
[38]郜丹,李晓菲,尹萍,等.基于炮制减毒思想的何首乌肝毒性物质基础初步研究[J].2017,(10).
[39]Chitturi S,Farrell GC.Herbal hepatotoxicity: an expanding but poorly defined problem.[J].2000,15(10).
[40]熊印华,刘晓杰,王新堂,等.基于脂肪酸代谢轮廓分析川楝子的肝毒性研究[J].2017,(15).
[41]Han,T.,Zhang,Q.-Y.,Qin,L.-P.,etc.Hepatotoxic constituents and toxicological mechanism of Xanthium strumarium L. fruits[J].2014,152(2).
[42]Changxiao Liu,Huirong Fan,Yazhuo Li,etc.Research Advances on Hepatotoxicity of Herbal Medicines in China[J].2016,2016(22).
[43].Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs[J].2016.
[44]Dong-Sheng Zhao,Li-Long Jiang,Ya-Xi Fan,etc.Investigation of Dioscorea bulbifera Rhizome-Induced Hepatotoxicity in Rats by a Multisample Integrated Metabolomics Approach[J].2017,30(10).
[45]陶玲,管咏梅,陈丽华,等.雷公藤配伍减毒研究进展[J].2018,(4).